Ruti Aga's six-year ban: a forged prescription destroyed the defence that real records could have saved

A half marathon was won in China in March, and the official time of that race appears in no report. What appears is paper: a prescription bearing the name of a clinic that does not exist, written by a family member of the athlete who holds no medical registration, and who, when asked, said he had used "an old prescription pad from a former workplace" that the clinic has explicitly disowned. In the Athletics Integrity Unit (AIU) statement, that sheet of paper sits at the centre of the case. Ethiopian marathoner Ruti Aga has been banned for six years. The raw sheet had two stories: one about the knee of a 32-year-old runner, one about the paper. I followed the one with a receipt.

Aga's career record needs to be stated in full first, because the ban headline has buried it. She won the 2026 Tokyo Marathon, a World Marathon Major title, and has three second-place finishes at Majors to her name. Her performance band sat between 2:18 and 2:20 (my archive holds 2:18:34 for second in Berlin 2026 and 2:20:40 for the Tokyo win in 2026; those figures belong to public result lists, not to the AIU statement). In an Ethiopia where an entire sub-2:16 generation exists, a 2:18–2:20 runner is not automatically selectable. That context matters because it explains her actual income stream: not Major podiums, but appearance fees at the label races scheduled between Majors.

The Chinese half marathon in March was that kind of race. The statement does not name it, does not give the time, does not describe the field. It says she won it and that a sample afterwards was positive. One technical point about road racing matters here: the in-competition testing window opens at 23:59 the day before the race. An injection given days earlier can still be caught if residue is present inside that window.

This is where a technical correction is required, and it is the legal hinge of the entire case. Media reports called methylprednisolone a "prohibited steroid" and said WADA classifies it as performance enhancing. That classification is wrong. Methylprednisolone is not an anabolic steroid (class S1) but a glucocorticoid — class S9 on the WADA Prohibited List — and it is prohibited in-competition only, by injection, oral or rectal routes. The direct consequence: a therapeutic knee injection is entirely legal out of competition and becomes a violation only if residue is present in-competition. The case was never about "steroid use"; it was about route and timing.

That is why Aga had a genuine defence available. Intra-articular or peri-articular methylprednisolone for knee synovitis is standard sports-medicine practice in distance runners. Had the knee treatment been documented — diagnosis, date, dose, the doctor's registration, a washout calculation — the argument would have been about a prohibited substance's residue, and it could have been won. Fabricating the prescription closed that path herself. The forged document arrived exactly where the real document was needed most.

The sanction arithmetic is plain: two years for presence of a prohibited substance, four for tampering, six in total. Two years is the standard outcome for a Specified Substance where intent is not proven. Four years is the Code's standard tampering sanction. The arithmetic also tells us the panel rejected the no-significant-fault route that would otherwise have cut the presence sanction. One paradox is worth recording: a forged document is itself circumstantial evidence of concealment intent, yet it did not escalate the presence sanction; it was counted on a separate ledger.

The "doctor" chapter aggravates rather than mitigates. Three independent verifications failed. The clinic did not exist. The writer held no medical registration and was family. The "old prescription pad" claim was disowned by the clinic itself. This is not a filing error; it is the signature of a camp operating without a credentialed team physician. I have a spreadsheet format built at Kalinga in 2026 in which every claim is attached to its paper basis; by that habit, the knee injury is the root cause here, and it is systemic rather than individual. An injured marathoner faces pressure to protect appearance-fee income, glucocorticoids are the cheapest and most available tool, and the surrounding medical network is informal. The forgery is downstream of that untreated governance gap.

The outcome is that a 32-year-old is out for six years — roughly 38 on return. In Ethiopia's women's marathon depth, a 38-year-old with a doping record is effectively unselectable. For elite purposes this is a lifetime ban. One thing should be kept clean: the violation is anchored to the March race, so results before that date — the 2026 Tokyo title and three Major second places — are not automatically annulled absent a finding of earlier use. The statement does not state the disqualification scope at all. In my experience AIU practice has been automatic disqualification of the competition where the sample was collected, including prize money; that is not said here.

This is where I part with the common reading. The "steroid" frame puts this case in the wrong queue: a glucocorticoid has no proven endurance benefit; it is an anti-inflammatory. And the six years is for paper, not for the drug — which is precisely the point both sides will read to their advantage. One reading will call it proof of AIU rigour, because enforcement has reached document verification. Another will call it disproportionate enforcement against East African road runners, where no entourage member has been charged and only a family member is named. I trust the archive more than the highlight reel, especially when money moves — and money moved here: the March prize purse, ranking points accrued after it, six years of lost earnings. Empty stadiums do not empty the ledger; they move the cost. Here the cost moved from the athlete to her entourage, and from the entourage to the informal medical network that no charge has touched.

What the file does not contain is also a finding. No race time, no race name, no year for March, no explicit year for the ban's start (the statement says only "provisionally suspended since 10 September"), no disqualification scope, and not one sentence from the Ethiopian federation — only the AIU statement. Before I call it culture, I want to see who kept the receipts. The receipts were not kept here, and what was not kept could have been the defence.

The real question ahead is not whether Aga returns — the arithmetic says no. It is where the AIU's next frontier sits. Document verification now decides cases as decisively as a urine sample, and the training clusters served by a single informal medical network have further cases in the pipeline. For me the indicator to watch is whether a future action names an agent or management, and whether the AIU publicly records the recovery of results and prize money from host road races. Until those two things enter the file, this case is both an example of rigour and an incomplete account.